MCK Trading Analysis - 10/09/2026 12:33 PM โ€” TRU-SENTIMENT

MCK (McKesson Corporation) at $936.23. True Sentiment Bullish, delta 40-60 call 75% / put 25%, call $111,670 vs put $36,660. RSI 67.4.

TRU-SENTIMENT ยท DeltaNeutral

MCK Trading Analysis - 10/09/2026 12:33 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

MCK (McKesson Corporation) at $936.23. True Sentiment Bullish, delta 40-60 call 75% / put 25%, call $111,670 vs put $36,660. RSI 67.4.

Symbol
MCK
Price
$936.23
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-09 12:33:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Call Volume: 111,670.00 (75.30%) Put Volume: 36,660.00 (24.70%) Total: 148,330.00

  • True Sentiment methodology: Delta 40-60 options only; 8 of 1788 total options analyzed, filter ratio 0.40%.
  • Sentiment is Bullish with call dollar volume dominating at 75.30% vs put 24.70%.
  • Directional conviction suggests near-term expectations remain to the upside, aligning with technical strength.
  • No notable divergence: both options flow and price action are bullish.
Note: Options flow shows heavy call buying at delta 40-60 strikes, supporting bullish continuation.

Key Statistics: MCK

$936.23 +0.17%
52-Week Range
$723.68 - $999.00
Market Cap
$109.16B
P/E (TTM)
24.80
PEG Ratio
N/A
Beta
0.17
Next Earnings
N/A
Avg Volume
$656,197
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)24.80
EPS (trailing 12 mo)$37.53
Market cap$109.16B
Shares outstanding116.6M

Dividend

Dividend yield0.40%
Annual dividend$3.76
Ex-dividend date2026-09-01

Risk & range

Beta0.17
52-week low$723.68
52-week high$999.00
Historical volatility26.2%

Ownership & trading

Institutional ownership58.3%
Average daily volume0.9M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

Recent general-knowledge headlines and context for McKesson Corporation (MCK) that may frame the current market environment:

  • McKesson reported fiscal Q1 2026 results in early August, with steady prescription-volume growth across its U.S. Pharmaceutical segment supporting full-year guidance.
  • The company announced a regular quarterly dividend with an ex-dividend date of September 1, 2026, maintaining its conservative payout relative to earnings.
  • Healthcare-distribution sector benefited from resilient demand and limited pricing pressure, though low beta (0.17) reflects defensive characteristics versus broader equities.
  • No major negative regulatory actions or supply-chain disruptions were widely reported heading into October 2026, consistent with stable institutional ownership near 58.3%.
  • Context: The constructive technical and options-sentiment picture below aligns with a defensively positioned large-cap that has trended higher from late-September lows without external shock headlines.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E is 24.80 with trailing EPS of 37.53; trailing PE suggests moderate large-cap valuation, though no forward PE, PEG, or sector comparison multiples were provided.
  • Market cap is 109,155,055,700.00 with shares outstanding of 116,590,000.00.
  • Dividend yield is 0.40% with dividend rate of 3.76 and ex-dividend date 2026-09-01.
  • Beta is 0.17, indicating very low sensitivity to market moves; 52-week range is 723.68 to 999.00.
  • Institutional ownership is 58.31%; average volume is 851,000.00 and historical volatility is 26.17%.
  • Key missing fundamentals: revenue growth, profit margins, ROE, debt/equity, free cash flow, analyst target price, and recommendation key are all null in the data.
  • Alignment: Low beta and stable institutional base are consistent with the steady uptrend and bullish options flow seen in the embedded technical and sentiment data.

Current Market Position

From the embedded minute and daily data:

  • Daily close on 2026-10-08 was 934.61; intraday minute bars on 2026-10-09 show last price at 936.23, with the session ranging 935.83 to 937.20 before noon.
  • Recent daily action: price rose from 855.83 (2026-09-30) to 934.61 (2026-10-08), a strong recovery within the 30-day range high 938.51 / low 847.28.
  • Minute bars show opening 906.65 on 2026-10-08 and steady climb to 936.23 by 2026-10-09 12:05, indicating positive intraday momentum.
Resistance
938.51
Support
906.65
Lower Support
882.44

Technical Analysis

Technical Indicators

Current Price
934.61
SMA 5
917.41
SMA 20
889.55
SMA 50
882.44
RSI 14
67.44
MACD
9.83
Signal
7.86
Histogram
1.97
Bollinger Mid
889.55
Bollinger Upper
933.70
Bollinger Lower
845.40
ATR 14
24.21
  • Price (934.61) is above SMA 5 (917.41), SMA 20 (889.55), and SMA 50 (882.44) โ€” bullish alignment, no bearish crossover.
  • RSI 14 at 67.44 shows strong momentum but not yet overbought (>70).
  • MACD (9.83) above signal (7.86) with positive histogram (1.97) confirms bullish momentum.
  • Price is just above Bollinger upper band (933.70), suggesting strong trend expansion rather than squeeze.
  • 30-day range: high 938.51, low 847.28; current price is near the top (~96% of range).

True Sentiment Analysis (Delta 40-60 Options)

Call Volume: 111,670.00 (75.30%) Put Volume: 36,660.00 (24.70%) Total: 148,330.00

  • True Sentiment methodology: Delta 40-60 options only; 8 of 1788 total options analyzed, filter ratio 0.40%.
  • Sentiment is Bullish with call dollar volume dominating at 75.30% vs put 24.70%.
  • Directional conviction suggests near-term expectations remain to the upside, aligning with technical strength.
  • No notable divergence: both options flow and price action are bullish.
Note: Options flow shows heavy call buying at delta 40-60 strikes, supporting bullish continuation.

Key Price Levels (Observational Only)

30d High / Resistance
938.51
SMA 5
917.41
SMA 20
889.55
SMA 50
882.44
Bollinger Lower
845.40

Interactive charts load with JavaScript. This text is the crawlable summary.